- Home
- TC vs ACON Comparison
TC vs ACON Comparison
Compare TC & ACON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TC
- ACON
- Stock Information
- Founded
- TC 2010
- ACON 2008
- Country
- TC China
- ACON United States
- Employees
- TC N/A
- ACON N/A
- Industry
- TC Business Services
- ACON Retail: Computer Software & Peripheral Equipment
- Sector
- TC Consumer Discretionary
- ACON Technology
- Exchange
- TC Nasdaq
- ACON Nasdaq
- Market Cap
- TC 1.7M
- ACON 1.7M
- IPO Year
- TC 2018
- ACON 2022
- Fundamental
- Price
- TC $0.92
- ACON $0.11
- Analyst Decision
- TC
- ACON Buy
- Analyst Count
- TC 0
- ACON 2
- Target Price
- TC N/A
- ACON $1.30
- AVG Volume (30 Days)
- TC 192.7K
- ACON 991.9K
- Earning Date
- TC 12-27-2024
- ACON 11-14-2024
- Dividend Yield
- TC N/A
- ACON N/A
- EPS Growth
- TC N/A
- ACON N/A
- EPS
- TC N/A
- ACON N/A
- Revenue
- TC $14,107,804.00
- ACON $49,289.00
- Revenue This Year
- TC N/A
- ACON N/A
- Revenue Next Year
- TC N/A
- ACON $186.36
- P/E Ratio
- TC N/A
- ACON N/A
- Revenue Growth
- TC N/A
- ACON N/A
- 52 Week Low
- TC $0.75
- ACON $0.10
- 52 Week High
- TC $4.30
- ACON $7.39
- Technical
- Relative Strength Index (RSI)
- TC 47.11
- ACON 30.75
- Support Level
- TC $0.82
- ACON $0.16
- Resistance Level
- TC $1.00
- ACON $0.20
- Average True Range (ATR)
- TC 0.09
- ACON 0.02
- MACD
- TC 0.01
- ACON -0.01
- Stochastic Oscillator
- TC 40.35
- ACON 13.37
About TC TuanChe Limited
TuanChe Ltd is an omnichannel automotive marketplace in China. The company operates in one operating segment of providing auto shows, special promotion events services, and virtual dealership, online marketing services, and others. It organizes auto shows, which aim at facilitating transactions between consumers and auto dealers that include auto dealers, automakers, and automotive service providers. It provides services through its online platform and offline events.
About ACON Aclarion Inc.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.